glp-1 anesthesia guidelines 2025 Updated guidance for patients using GLP-1/GIP receptor agonists GLP-1 drugs and aspiration risk

17 Gallbladder disease, including gallstone formation known as cholelithiasis and inflammation of the gallbladder called cholecystitis, is a major problem, especially in people with obesity and T2DM, the population groups most frequently treated with GLP-1RAs

The difference is cost and accessibility, not therapeutic effectiveness

However, sensitivity analyses, which involved excluding individual studies, revealed that omitting one outlier study [22], characterized by substantial variability compared to the others, resulted in a significant increase in WL for the GLP-1RAs group (SMD = 0.82

Following liraglutide treatment, the upregulation of microglial cell number and proinflammatory factors was markedly decreased, and microglia exhibited much longer process lengths in the TNC

There was also an increase in heart rate noted

GLP-1 receptors can be found in a variety of tissues such as the pancreas, gastric mucosa, kidney, lung, heart, skin, immune cells, and brain